The United States officially won't be involved in an enhanced pandemic global response enacted by the World Health ...

Following on from their breakthrough human trial that successfully reprogrammed the immune system to overpower glioblastoma, an aggressive brain tumor, the same scientists have now further developed ...

The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...

No improvement in clinical outcomes occurred among inpatients with COVID-19 who received nirtmatrelvir-ritonavir or molnupiravir in addition to usual care.

A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney ...

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

Cancer patients who receive COVID boosters are far less likely to be hospitalized, but vaccination rates remain alarmingly ...

The rate of COVID-related intensive care unit (ICU) admissions was 9.2 per 1,000 person-years among patients who received a ...

Despite offering significant protection against severe COVID-19, patients with cancer, a high-risk group, showed low uptake of booster vaccinations.

Feline infectious peritonitis, or FIP, is a serious and historically fatal disease in cats caused by a coronavirus. It behaves in many ways like severe coronavirus infections in humans, causing ...

Potential risks of self-medication include incorrectly self-diagnosing and taking the wrong medication, which leads to several complications, hence making it harder to treat illnesses.

Respiratory infections such as COVID-19 have been responsible for numerous pandemics and have placed a substantial burden on ...